65,437 trials
Pain
Primary: Patient Global Rating of Pain for the Study Period (12 Weeks) — 19; 25; 27; 28 participants
Neuropathic Pain
Primary: Neuropathic Pain in Subjects With Peripheral Neuropathic Pain Conditions During the Double-blind Phase — 2.84; 3.62 score on scale — p=0.0018
Impotence
Primary: Change From Baseline to Endpoint in the International Index of Erectile Function (IIEF)- Erectile Function Domain Score (Sum of IIEF Questions 1-5 and 15) — 0.49; 8.03…
Breast Cancer · Breast Neoplasms, Male · Carcinoma, Ductal
Primary: Overall Tumor Response — 1; 8; 14; 9 participants
Pulmonary Disease, Chronic Obstructive
Primary: FEV1 AUC0-6 at Day 85 — 0.145; 0.149; 0.119 liters — p=0.7135
Placenta, Retained · Postpartum Hemorrhage
Primary: Placental Retention Rate — 26; 8; 24 participants — p=0.05
Prophylaxis Of Invasive Fungal Infections
Primary: Occurrence of Proven or Probable Invasive Fungal Infection (IFI): Start of Prophylaxis Until 12-month Follow-up Visit — 3 participants
Colorectal Neoplasms · Liver Neoplasms
Primary: Disease Free Survival (DFS) — 21.6; 24.7 months — p=0.468
Migraine Headache
Primary: Change in Number of Migraine Episodes Per 30 Days at Month 10. — -2.1; -2.1; -2.2; -3.3 Number of Migraine episodes — p=< .01
Glaucoma
Primary: Change in Intraocular Pressure (IOP) From Baseline at 8 Weeks — -2.50; -1.82; -2.78 mmHg
Angina Pectoris · Angina, Unstable · Myocardial Infarction
Primary: Spectral Similarity — 83 percent similarity
Breast Cancer
Primary: Seroma Formation — 770.48; 1089.51 ml
Influenza Vaccines
Primary: Geometric Mean Titers (GMTs) of Anti-H3 and B Strains — 369.6; 331.2; 269.6; 245.0 Titer
Bipolar I Disorder
Primary: Mean Change in Young Mania Rating Scale (YMRS) Scores From Baseline to Endpoint. — -10.15; -7.68 units on a scale — p=<0.001
Hepatitis B Vaccine
Primary: Number of Participants With Anti-hepatitis B Surface Antigen (HBs) Antibody Concentrations Above the Cut-off Value — 275 Participants